(Q43932153)

English

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

scientific article published on 19 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

hospitalization

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

28 November 2017

10

object named as

Faiez Zannad

1 reference

Europe PubMed Central

28 November 2017

9

object named as

Bertram Pitt

1 reference

Europe PubMed Central

28 November 2017

3

object named as

Naveed Sattar

1 reference

Europe PubMed Central

28 November 2017

5

object named as

Karl Swedberg

1 reference

Europe PubMed Central

28 November 2017

4

object named as

Henry Krum

1 reference

Europe PubMed Central

28 November 2017

Dirk J van Veldhuisen

2

object named as

Dirk J van Veldhuisen

1 reference

Europe PubMed Central

28 November 2017

11

object named as

John J V McMurray

1 reference

Europe PubMed Central

28 November 2017

6

object named as

Harry Shi

1 reference

Europe PubMed Central

28 November 2017

author name string

John Vincent

7

1 reference

Europe PubMed Central

28 November 2017

Stuart J Pocock

8

1 reference

Europe PubMed Central

28 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 May 2012

1 reference

Europe PubMed Central

28 November 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

28 November 2017

14

1 reference

Europe PubMed Central

28 November 2017

8

1 reference

Europe PubMed Central

28 November 2017

909-915

1 reference

Europe PubMed Central

28 November 2017

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Effect of valsartan on the incidence of diabetes and cardiovascular events

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Effect of eplerenone versus spironolactone on cortisol and hemoglobin A₁(c) levels in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Eplerenone in patients with systolic heart failure and mild symptoms

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Aldosterone production and insulin resistance in healthy adults

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Low serum potassium levels and risk of type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS 1).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Animal and human tissue Na,K-ATPase in obesity and diabetes: A new proposed enzyme regulation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Endogenous sodium pump inhibitors, diabetes mellitus and preeclampsia Preliminary observations and a hypothesis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Predicting the 20-year diabetes incidence rate.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS067

21 January 2018

Identifiers

10.1093/EURJHF/HFS067

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43932153&oldid=2104476052"